Synthesis of a new class of pyrrolo[3,4-h]quinazolines with antimitotic activity
摘要:
A new series of pyrrolo[3,4-h]quinazolines was conveniently prepared with a broad substitution pattern. A large number of derivatives was obtained and the cellular cytotoxicity was evaluated in vitro against 5 different human tumor cell lines with GI(50) values reaching the low micromolar level (1.3-19.8 mu M). These compounds were able to induce cell death mainly by apoptosis through a mitochondrial dependent pathway. Selected compounds showed antimitotic activity and a reduction of tubulin polymerization in a concentration-dependent manner. Moreover, they showed anti-angiogenic properties since reduced in vitro endothelial cell migration and disrupted HUVEC capillary-like tube network in Matrigel. (C) 2013 Elsevier Masson SAS. All rights reserved.
[EN] NEW THERAPEUTIC AGENTS FOR THE TREATMENT OF HAEMATOLOGICAL PATHOLOGIES<br/>[FR] NOUVEAUX AGENTS THÉRAPEUTIQUES POUR LE TRAITEMENT DE PATHOLOGIES HÉMATOLOGIQUES
申请人:UNIV DEGLI STUDI DI PALERMO
公开号:WO2021038452A1
公开(公告)日:2021-03-04
The present invention relates to compounds having a tetracyclic system and the use thereof as new therapeutic agents in the treatment of acute myeloid leukemia (AML), preferably in FLT3/ITD hemizygote patients resistant to conventional therapies. The invention also relates to 5,7-dihydro-4H-[1,3]thiazolo[4,5-e]isoindol-2-amine compounds useful as intermediates for the synthesis of tetracyclic imidazo[2',1':2,3][1,3]thiazolo[4,5-e]isoindole compounds.
A series of [1,3]thiazolo[4,5-e]isoindoles has been synthesized through a versatile and high yielding multistep sequence. Evaluation of the antiproliferative activity of the new compounds on the full NCI human tumor cell line panel highlighted several compounds that are able to inhibit tumor cell proliferation at micromolar-submicromolar concentrations. The most active derivative 11g was found to cause
通过通用且高产率的多步骤序列合成了一系列[1,3]噻唑并[4,5- e ]异吲哚。对新化合物在完整的NCI人肿瘤细胞系中的抗增殖活性的评估突出了几种能够在微摩尔-亚微摩尔浓度下抑制肿瘤细胞增殖的化合物。发现最活跃的衍生物11g沿着线粒体途径,导致细胞周期停滞在G2 / M期并诱导HeLa细胞凋亡,使其成为发现新抗有丝分裂药物的先导化合物。
Pyrano[2,3-e]isoindol-2-ones, new angelicin heteroanalogues
synthesis of the pyrano[2,3-e]isoindol-2-one ring system, an heteroanalogue of angelicin, is reported. Our synthetic approach consists of the annelation of the pyran ring on the isoindole moiety using 5-dialkylamino- or 5-hydroxymethylene intermediates as building blocks. The photoantiproliferative activity of the newderivatives was studied. Some of them bearing the benzyl group at the 8 position
据报道,吡喃并[2,3 - e ] isoindol-2-one环系统,即当归的杂类似物,可以方便地合成。我们的合成方法包括使用5-二烷基氨基-或5-羟基亚甲基中间体作为结构单元,使吡喃环在异吲哚部分上的成环反应。研究了新衍生物的光抗增殖活性。其中一些在8位带有苄基的化合物在微摩尔范围内具有IC 50活性。细胞的细胞毒性涉及细胞凋亡,细胞周期概况的改变和膜的光损伤。
NEW THERAPEUTIC AGENTS FOR THE TREATMENT OF HAEMATOLOGICAL PATHOLOGIES